Never miss a trade again with the fastest news alerts in the world!
 This headline only article is a sample of real-time intelligence
 <a href="https://benzinga.grsm.io/headlineonlyarticles3398">Benzinga Pro</a> traders use to win in the markets everyday.
 Want the fastest, most accurate stock market intelligence? Want EXCLUSIVE stories originated by Benzinga reporters?
 <a href="https://benzinga.grsm.io/headlineonlyarticles3398">Join 10,000+ serious traders in the Benzinga Pro community!</a>

NLS Pharmaceutics And Kadimastem Enter Binding Term Sheet For Transaction Under Which Kadimastem will Become A Wholly Owned Subsidiary Of NLS; Kadimastem's Shareholders To Hold 85% Of Issued And Outstanding Shares Of Merged Company - NLS Pharmaceutics (NASDAQ:NLSP)

Benzinga Newsdesk

NLS Pharmaceutics

NLSP

NLS Pharmaceutics And Kadimastem Enter Binding Term Sheet For Transaction Under Which Kadimastem will Become A Wholly Owned Subsidiary Of NLS; Kadimastem's Shareholders To Hold 85% Of Issued And Outstanding Shares Of Merged Company

Comments